Published • loading... • Updated
American Society of Gene and Cell Therapy Awards Beverly L. Davidson, PhD, Outstanding Achievement Award
The society cited her pioneering Huntington’s disease research, viral vector engineering and mentorship of translational scientists.
- The American Society of Gene and Cell Therapy honored Beverly L. Davidson, PhD, with the Outstanding Achievement Award at its annual meeting in Boston on Thursday, recognizing her lifetime contributions to gene and cell therapy.
- Davidson serves as Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics and Chief Scientific Strategy Officer at CHOP, where she leads translational research into inherited brain diseases.
- Her foundational discoveries in Huntington disease include engineering AAV variants and pioneering early RNAi development to target neural tissues, advancing research toward potentially disease-modifying therapies.
- "Her leadership transformed how the field develops brain-directed genetic medicines," said Susan Furth, Executive Vice President at CHOP, while CEO David Barrett called her influence "lasting" across challenging diseases.
- Beyond her research, Davidson mentored scientists now leading independent programs at other institutions and thanked ASGCT for advancing genetic medicines that are "potent, safe, scalable and accessible.
Insights by Ground AI
15 Articles
15 Articles
ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy
BOSTON – Geneticist Beverly Davidson, PhD, received the 2026 Outstanding Achievement Award from the American Society of Gene and Cell Therapy (ASGCT). Davidson is currently the chief scientific strategy officer at the Children’s Hospital of Philadelphia (CHOP) and a former president of ASGCT. Some of the research Davidson presented was conducted at a new biotech company she co-founded called Latus Bio, which earlier this month announced it had r…
Coverage Details
Total News Sources15
Leaning Left1Leaning Right1Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 17%
C 67%
R 16%
Factuality
To view factuality data please Upgrade to Premium
